News
-
-
-
COMMUNIQUÉ DE PRESSE
Bio-Gate AG: First Comparative Clinical Data on HyProtect™ in Trauma Care—Significantly Higher Treatment Success Rate for Infected, Non-Healed Femur Fractures
Bio-Gate AG releases first comparative clinical data on HyProtect™ technology showing significantly higher success rates and lower costs in trauma care for infected, non-healed femur fractures -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Bio-Gate AG: Resolves to Conduct a Capital Increase from Authorized Capital and Announces the Terms of the Rights Offering Approved by the Annual General Meeting on June 30, 2026
Bio-Gate AG resolves to conduct a capital increase from authorized capital and announces terms of rights offering, aiming to strengthen financial flexibility and implement growth strategy efficiently -
